全球肾神经阻断导管市场 - 市场规模（依细分市场）、占有率、监管、偿付、程序、预测（至2033年）

全球高血压流行是肾神经阻断导管市场的最大驱动因素之一。高血压通常可以透过改变生活型态和处方药物来控制，但有时即使使用三种或更多抗高血压药物（包括利尿剂）也无法达到血压目标。此类病例称为顽固性高血压。如果不及时治疗，可能会导致多种併发症。据观察，顽固性高血压与交感神经系统的慢性活化有关。该药可以透过减少交感传入和传出肾神经的活动来降低血压。肾去神经术是一种短期、长期治疗方法，可为难治性高血压患者提供替代治疗。

本报告研究和分析了全球肾神经阻断导管市场，提供了有关主要参与者和市场占有率、主要趋势、创新产品和技术以及竞争格局的资讯。

市场模型的主要内容如下。

已上市的肾神经阻断导管和不断变化的竞争格局

• 对主要产业趋势的考察
• 肾神经阻断导管市场各细分市场的年收入及市场前景（2015-2033年）
• 依细分市场划分的手术总数、单位数量、平均售价和市场价值的详细资料

全球、区域和国家层面的特定市场考察

• 依地区细分全球趋势的特定市场定性资讯和国家考察
• 肾神经阻断导管市场SWOT分析
• 肾神经阻断导管市场竞争动态的考察与趋势

透过对医疗保健系统的真实、全面的了解来促进市场理解。市场进入部分还提供有关偿付政策和监管环境的讯息，能够更深入地研究市场动态。

• 各国医疗保健系统概览
• 依国家/地区划分的偿付政策
• 各国医疗科技监理状况

目标公司

• Medtronic Plc
• Boston Scientific Corp
• Abbott laboratories
• ReCor Medical Inc
• 其他

Renal Denervation Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.

Renal denervation, also known as renal sympathetic denervation (RSD), is a minimally invasive, catheter-based endovascular procedure that utilizes radiofrequency energy or ultrasound energy to ablate nerves in the walls of the renal artery, causing a reduction in the nerve activity which ultimately reduces the blood pressure in patients with resistant hypertension.

The global prevalence of hypertension is one of the largest drivers in the renal denervation market. While hypertension can usually be controlled with lifestyle modifications and taking medications as prescribed, there are cases where the target blood pressure cannot be achieved even with three or more antihypertensive drugs (including a diuretic). Such cases are termed resistant hypertensive cases. If left untreated, several comorbidities can result. It has been observed that resistant hypertension can be associated with chronic activation of the sympathetic nervous system. By reducing the activity of sympathetic afferent and efferent renal nerves, it may be possible to lower blood pressure. Renal denervation is a quick and potentially long-lasting treatment option and has the potential to provide an alternative therapeutic approach for patients suffering from resistant hypertension.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Renal Denervation Catheters and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Renal Denervation Catheters market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Renal Denervation Catheters market.
• Competitive dynamics insights and trends provided for Renal Denervation Catheters market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Medtronic Plc, Boston Scientific Corp, Abbott laboratories, ReCor Medical Inc, and Others.

Countries covered: United States, Canada, Mexico, France, Germany, Italy, Spain, United Kingdom, Russia, Austria, Greece, Sweden, Switzerland, Australia, China, India, Japan, South Korea, Brazil, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Renal Denervation Catheters marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Renal Denervation Catheters market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Renal Denervation Catheters market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Renal Denervation Catheters market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.